Hvsen Biotechnology Co., Ltd. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 671.48 million compared to CNY 745.91 million a year ago. Revenue was CNY 671.48 million compared to CNY 745.91 million a year ago.

Net income was CNY 26.41 million compared to CNY 119.73 million a year ago. Basic earnings per share from continuing operations was CNY 0.16 compared to CNY 0.72 a year ago. Diluted earnings per share from continuing operations was CNY 0.16 compared to CNY 0.72 a year ago.